Evidence map›Paper›PMID 24936775›Full record

ArticleJournal of psychiatry & neuroscience : JPN2014

Investigation of the involvement of MIR185 and its target genes in the development of schizophrenia.

Andreas J Forstner, F B Basmanav, Manuel Mattheisen, Anne C Böhmer, Mads V Hollegaard, Esther Janson, Eric Strengman, Lutz Priebe, Franziska Degenhardt, Per Hoffmann and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of psychiatry & neuroscience : JPN, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. miR-185 mediates lung epithelial cell death after oxidative stress.American journal of physiology. Lung cellular and molecular physiology · 2016
    Article
  15. Article
  16. Heterogeneity and individuality: microRNAs in mental disorders.Journal of neural transmission (Vienna, Austria : 1996) · 2015
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 7 institutions in 5 countries.

Andreas J ForstnerThe Institute of Human Genetics, University of Bonn, and the Department of Genomics, Life and Brain Center, Bonn, Germany.
F B BasmanavThe Institute of Human Genetics, University of Bonn, and the Department of Genomics, Life and Brain Center, Bonn, Germany.
Manuel MattheisenThe Department of Biomedicine, Human Genetics, and Centre for Integrative Sequencing, iSEQ, Aarhus University, the The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, and Copenhagen, Denmark, and the Department of Genomics Mathematics, University of Bonn, Germany.
Anne C BöhmerThe Institute of Human Genetics, University of Bonn, and the Department of Genomics, Life and Brain Center, Bonn, Germany.
Mads V HollegaardThe Section of Neonatal Screening and Hormones, Statens Serum Institute, Copenhagen, Denmark.
Esther JansonThe Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, the Netherlands.
Eric StrengmanThe Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, the Netherlands.
Lutz PriebeThe Institute of Human Genetics, University of Bonn, and the Department of Genomics, Life and Brain Center, Bonn, Germany.
Franziska DegenhardtThe Institute of Human Genetics, University of Bonn, and the Department of Genomics, Life and Brain Center, Bonn, Germany.
Per HoffmannThe Institute of Human Genetics, University of Bonn, the Department of Genomics, Life and Brain Center, Bonn, Germany, and the Division of Medical Genetics, University Hospital Basel and Department of Biomedicine, University of Basel, Switzerland.
Stefan HermsThe Institute of Human Genetics, University of Bonn, the Department of Genomics, Life and Brain Center, Bonn, Germany, and the Division of Medical Genetics, University Hospital Basel and Department of Biomedicine, University of Basel, Switzerland.
Wolfgang MaierThe Department of Psychiatry, University of Bonn, Germany.
Rainald MössnerThe Department of Psychiatry, University of Bonn, Germany.
Dan RujescuThe Department of Psychiatry, University of Halle-Wittenberg, Halle, Germany.
Roel A OphoffThe Center for Neurobehavioral Genetics, University of California Los Angeles, USA and the Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center, Utrecht, the Netherlands.
Susanne MoebusThe Institute of Medical Informatics, Biometry and Epidemiology, University Duisburg-Essen, Essen, Germany.
Preben B MortensenThe Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus and Copenhagen, the National Centre for Register-based Research, Aarhus University, Aarhus, Denmark.
Anders D BørglumThe Department of Biomedicine, Human Genetics, and Centre for Integrative Sequencing, iSEQ, Aarhus University, the The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus and Copenhagen, and the Centre for Psychiatric Research, Aarhus University Hospital, Risskov, Denmark.
David M HougaardThe Section of Neonatal Screening and Hormones, Statens Serum Institute, Copenhagen, Denmark.
Josef FrankDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Germany.
Stephanie H WittThe Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Germany.
Marcella RietschelThe Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Germany.
Andreas ZimmerThe Institute of Molecular Psychiatry, University of Bonn, Germany.
Markus M NöthenThe Institute of Human Genetics, University of Bonn, and the Department of Genomics, Life and Brain Center, Bonn, Germany.
Xavier MiróThe Institute of Molecular Psychiatry, University of Bonn, Germany.
Sven CichonThe Institute of Human Genetics, University of Bonn, the Department of Genomics, Life and Brain Center, Bonn, the Institute of Neuroscience and Medicine INM-1, Research Center Juelich, Germany and the Division of Medical Genetics, University Hospital Basel and Department of Biomedicine, University of Basel, Switzerland.
University of Bonn · DEStatens Serum Institut · DKUniversity Medical Center Utrecht · NLHeidelberg University · DEAarhus University · DKLife & Brain (Germany) · DELundbeck Foundation · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSchizophrenia is a complex neuropsychiatric disorder of unclear etiology. The strongest known genetic risk factor is the 22q11.2 microdeletion. Research has yet to confirm which genes within the deletion region are implicated in schizophrenia. The minimal 1.5 megabase deletion contains MIR185, which encodes microRNA 185.

methodsWe determined miR-185 expression in embryonic and adult mouse brains. Common and rare variants at this locus were then investigated using a human genetics approach. First, we performed gene-based analyses for MIR185 common variants and target genes using Psychiatric Genomics Consortium genome-wide association data. Second, MIR185 was resequenced in German patients (n = 1000) and controls (n = 500). We followed up promising variants by genotyping an additional European sample (patients, n = 3598; controls, n = 4082).

resultsIn situ hybridization in mice revealed miR-185 expression in brain regions implicated in schizophrenia. Gene-based tests revealed association between common variants in 3 MIR185 target genes (ATAT1, SH3PXD2A, NTRK3) and schizophrenia. Further analyses in mice revealed overlapping expression patterns for these target genes and miR-185. Resequencing identified 2 rare patient-specific novel variants flanking MIR185. However, follow-up genotyping provided no further evidence of their involvement in schizophrenia. LIMITATIONS: Power to detect rare variant associations was limited.

conclusionHuman genetic analyses generated no evidence of the involvement of MIR185 in schizophrenia. However, the expression patterns of miR-185 and its target genes in mice, and the genetic association results for the 3 target genes, suggest that further research into the involvement of miR-185 and its downstream pathways in schizophrenia is warranted.

Indexed as

AcetyltransferasesAnimalsBrainGenetic VariationGenome-Wide Association StudyGenotyping TechniquesHeterocyclic CompoundsHumansIn Situ HybridizationMice, Inbred C57BLMicroRNAsMicrotubule ProteinsReceptor, trkCSchizophreniaWhite People3-decyl-1,5,8-triazacyclodecane-2,4-dioneAcetyltransferasesATAT1 protein, mouseHeterocyclic CompoundsMicroRNAsMicrotubule ProteinsMIRN185 microRNA, humanMirn185 microRNA, mouseReceptor, trkC

Identifiers

PMID24936775
PMCPMC4214873
OpenAlexW1963904642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.